Verastem | VSTM - Equity Capital And Reserves

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $-32.43M in Equity Capital and Reserves for its fiscal quarter ending in March of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
Alaunos Therapeutics USD 2.8M 858K Sep/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Cytokinetics USD -521.12M 216.32M Sep/2025
Gilead Sciences USD 22.62B 1.16B Dec/2025
Incyte USD 5.17B 516.28M Dec/2025
Laboratory Of America USD 8.71B 240.3M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 607.22M 330.79M Sep/2025
Verastem USD -32.43M 3.54M Mar/2025